Kezar toplines small Phase 2a dataset in autoimmune liver diseasenews2025-03-25T14:57:56+00:00March 25th, 2025|Endpoints News|
GSK to research whether shingles vaccine can cut dementia risknews2025-03-25T10:48:44+00:00March 25th, 2025|Endpoints News|
FDA’s biologics chief stresses need for vaccine transmission datanews2025-03-24T18:37:19+00:00March 24th, 2025|Endpoints News|
Two biotechs fail to beat or match Regeneron’s Eylea in key trialsnews2025-03-24T15:34:29+00:00March 24th, 2025|Endpoints News|
Novo Nordisk pays $200M upfront for United Laboratories International Holdings’ triple-G obesity shotnews2025-03-24T11:41:59+00:00March 24th, 2025|Endpoints News|
Biogen plans to open new headquarters in Boston area in 2028news2025-03-24T11:30:12+00:00March 24th, 2025|Endpoints News|
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in Chinanews2025-03-21T15:24:18+00:00March 21st, 2025|Endpoints News|
ACIP meeting, delayed earlier this year, is reschedulednews2025-03-20T21:22:20+00:00March 20th, 2025|Endpoints News|
Akero exec calls MASH accelerated approval guidance ‘bizarre’news2025-03-20T19:41:09+00:00March 20th, 2025|Endpoints News|
Monte Rosa reports first data for molecular glue programnews2025-03-20T11:47:30+00:00March 20th, 2025|Endpoints News|
